One-year clinical outcomes of four-dose induction versus immediate treat-and-extend faricimab regimens in pretreated neovascular age-related macular degeneration
Authors
- Lucas M. Bachmann (ORCID: https://orcid.org/0000-0002-9868-154X)
- A. Paris (ORCID: https://orcid.org/0000-0002-2908-3802)
- Moreno Menghini (ORCID: https://orcid.org/0000-0002-1432-2524)
- Martin Schmid (ORCID: https://orcid.org/0000-0001-5341-9209)
- Gabriela Grimaldi (ORCID: https://orcid.org/0000-0003-2435-7867)
Institutions
- University of Lucerne (CH)
- Prevention Institute (US)
- Ente Ospedaliero Cantonale (CH)
- Medignition (Switzerland) (CH)